---
figid: PMC7465511__cells-09-01901-g002
figtitle: 'MPN: The Molecular Drivers of Disease Initiation, Progression and Transformation
  and their Effect on Treatment'
organisms:
- Mus musculus
- Microtus arvalis
- Homo sapiens
- Syringa vulgaris
pmcid: PMC7465511
filename: cells-09-01901-g002.jpg
figlink: pmc/articles/PMC7465511/figure/cells-09-01901-f002/
number: F2
caption: 'The molecular signalling pathways involved in MPN: The cell surface receptors
  are erythropoietin receptor (EPOR; red) and thrombopoietin receptor/MPL (navy blue),
  MPL with mutated Calreticulin (CALR), wildtype MPL with no ligand (thrombopoietin
  (TPO)) bound and no STAT signalling, wildtype EPOR with bound ligand (erythropoietin
  (EPO)) leading to STAT signalling, EPOR with JAK2 mutant, MPL with JAK2 mutant and
  mutated MPL. The cytoplasm shows STAT pathway signalling with activation of phosphatidylinositol
  3-kinase (PI3K)/Akt and RAS pathways, and the nucleus (lilac background) shows the
  effects of driver and coexisting mutations on nuclear functions. Headings for DNA
  methylation modifiers, tumour suppressors, transcription regulators, spliceosome
  complex and chromatin modification identify the key sites of coexisting mutations.
  Abbreviations not mentioned in the body of the article: STAT, signal transducers
  and activators of transcription; PI3K, phosphatidylinositol 3-kinase; Akt, Protein
  kinase B; mTOR, mammalian target of rapamycin; SUZ12, suppressor of zeste 12 homolog;
  EEZ, embryonic ectoderm development; BAP1, BRCA1-associated protein 1; BRD4, bromodomain
  containing protein 4; BCL-2, B cell lymphoma 2; BCL-XL, B cell lymphoma extra large;
  Ac, acetylated; Me, methylated; Ub, ubiquitinated; P, phosphorylated; mut, mutated.'
papertitle: 'MPN: The Molecular Drivers of Disease Initiation, Progression and Transformation
  and their Effect on Treatment.'
reftext: Julian Grabek, et al. Cells. 2020 Aug;9(8):1901.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9221996
figid_alias: PMC7465511__F2
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
redirect_from: /figures/PMC7465511__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7465511__cells-09-01901-g002.html
  '@type': Dataset
  description: 'The molecular signalling pathways involved in MPN: The cell surface
    receptors are erythropoietin receptor (EPOR; red) and thrombopoietin receptor/MPL
    (navy blue), MPL with mutated Calreticulin (CALR), wildtype MPL with no ligand
    (thrombopoietin (TPO)) bound and no STAT signalling, wildtype EPOR with bound
    ligand (erythropoietin (EPO)) leading to STAT signalling, EPOR with JAK2 mutant,
    MPL with JAK2 mutant and mutated MPL. The cytoplasm shows STAT pathway signalling
    with activation of phosphatidylinositol 3-kinase (PI3K)/Akt and RAS pathways,
    and the nucleus (lilac background) shows the effects of driver and coexisting
    mutations on nuclear functions. Headings for DNA methylation modifiers, tumour
    suppressors, transcription regulators, spliceosome complex and chromatin modification
    identify the key sites of coexisting mutations. Abbreviations not mentioned in
    the body of the article: STAT, signal transducers and activators of transcription;
    PI3K, phosphatidylinositol 3-kinase; Akt, Protein kinase B; mTOR, mammalian target
    of rapamycin; SUZ12, suppressor of zeste 12 homolog; EEZ, embryonic ectoderm development;
    BAP1, BRCA1-associated protein 1; BRD4, bromodomain containing protein 4; BCL-2,
    B cell lymphoma 2; BCL-XL, B cell lymphoma extra large; Ac, acetylated; Me, methylated;
    Ub, ubiquitinated; P, phosphorylated; mut, mutated.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Tpo
  - Thpo
  - Slc25a19
  - Epor
  - Mpl
  - Mmut
  - Jak2
  - ras
  - Hras
  - Kras
  - Rem1
  - Zhx2
  - Pik3r1
  - Trp53
  - Idh2
  - Mdk
  - Akt1
  - Atp5f1a
  - Mom6
  - Bcl2l1
  - Bcl2
  - Mtor
  - Ephb2
  - Mapk1
  - ac
  - Idh1
  - Tet2
  - Jarid2
  - Brd4
  - Suz12
  - Eed
  - Ezh2
  - Me3
  - Hoxa
  - smc
  - Zrsr2
  - Srsf2
  - Gm6687
  - U2af1
  - Bap1
  - Magi1
  - Dnmt3a
  - Sox4
  - Meis1
  - Tal1
  - Gata1
  - Runx1
  - TPO
  - THPO
  - CCDC6
  - SLC25A19
  - EPOR
  - MPL
  - MMUT
  - JAK2
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - TP53
  - TP63
  - TP73
  - IDH2
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - AKT1
  - AKT2
  - AKT3
  - ATP5F1A
  - BCL2L1
  - BCL2
  - FOXO1
  - FOXO3
  - FOXO4
  - FOXO6
  - MTOR
  - EPHB2
  - MAPK1
  - MAPK3
  - ADCY1
  - ADCY2
  - ADCY3
  - ADCY4
  - ADCY5
  - ADCY6
  - ADCY7
  - ADCY8
  - ADCY9
  - ADCY10
  - IDH1
  - TET2
  - EED
  - EZH1
  - EZH2
  - SUZ12
  - JARID2
  - BRD4
  - PI3
  - ME3
  - PCDHGA5
  - DYM
  - ZRSR2
  - SRSF2
  - U2AF1
  - BAP1
  - RNF2
  - MAGI1
  - DNMT3A
  - SOX4
  - HIF1A
  - EPAS1
  - HIF3A
  - ARNT
  - ARNT2
  - BMAL1
  - MEIS1
  - TAL1
  - GATA1
  - RUNX1
  - Ac
  - Me
---
